LAO: Counties Need 2,400+ New Eligibility Workers for H.R. 1 — Zero Funded, Creating Second Disenrollment Pathway
The CA Legislative Analyst's Office details the massive staffing gap counties face implementing H.R. 1. Counties estimate needing 2,000+ additional Medi-Cal eligibility workers and 400+ CalFresh workers statewide.
The Governor's budget proposes $2.4B for Medi-Cal county administration but includes zero funding for new positions. Starting October 2026, H.R. 1 also cuts federal CalFresh administrative cost share from 50% to 25%.
The CWDA warns of 'longer application processing times' and heightened churn where eligible people temporarily lose benefits due to processing backlogs.
For FQHCs: patients will lose coverage through administrative delays — not just work requirements — a second disenrollment vector driving uncompensated care.
Primary source
CA Legislative Analyst's Office / CWDASource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, March 5). LAO: Counties Need 2,400+ New Eligibility Workers for H.R. 1 — Zero Funded, Creating Second Disenrollment Pathway. Primary source: CA Legislative Analyst's Office / CWDA. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/lao-county-staffing-gap-hr1-administrative-churn
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge